Gary Kleiger (Chemistry) participated in an international collaboration with Brenda Schulman, director of the Max Planck Institute of Biochemistry. Published this week in Nature, their article describes at atomic structural resolution how enzymes called ubiquitin ligases function in human cells. How these enzymes work is also of considerable importance to a blossoming, new drug discovery area in biotechnology called targeted protein degration.
